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Identity 
Note: Ewing tumours form a histologically 
heterogeneous family belonging to the group of small 
round-cell tumours and derived from neural crests cells. 
Classification 
Ewing's tumors cover several distinct histological 
types: 
- Peripheral neuroepithelioma, 
- Esthesioneuroblastoma, 
- Askin's tumour, 
- Ewing's sarcoma of bones and soft tissues. 
Clinics and pathology 
Epidemiology 
Peripheral neuroepithelioma is a very rare tumour (1%  
of all sarcomas); Ewing's sarcoma represents 5 to 15%
of malignant bone and soft tissue tumours; two thirds 
of cases of Ewing's tumours occur before age 35 years, 
with a median age of 20 years. 
Clinics 
Peripheral neuroepithelioma typically occurs in the 
extremities (buttock and upper thigh, shoulder and 
upper arm); 
Esthesioneuroblastoma probably develops from the 
olfactive placode, in the nasal vault; 
Ewing's sarcoma of bones affects preferentially long 
bones (especially the femur), the pelvis, and the ribs; 
Extraskeletal Ewing's sarcoma occur in the 
paravertebral region and chest wall, often in associati n 
with vertebrae and ribs, and in lower extremities; 
Askin's tumour is a pediatric tumour affecting mostly 
the chest wall and ribs. 
  
Ewing's tumor: the tumor is composed of blastematous tissue with some differentiated glomerular structures associated with 
mesenchymal tissue and tubules. Courtesy Pierre Bedossa. 
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Pathology 
Peripheral neuroepithelioma shows sheets or lobules of 
small round-cells with a scarce cytoplasm; cells are
often arranged in rosettes with a neurofibrillar center 
(Homer-Wright rosettes). 
Esthesioneuroblastoma is histologically very similar to 
neuroblastoma; rosettes may be present. 
Askin's tumour seems to be more related to 
neuroepithelioma than to Ewing's sarcoma. 
Ewing's sarcoma forms sheets of uniform small round-
cells, sometimes arranged in a lobular pattern; the 
cytoplasm is scanty, pale stained and often vacuolated 
(glycogen); Ewing's sarcoma is considered as the less 
differentiated form of the Ewing's tumours family. 
Treatment 
The treatment of Ewing's tumours is generally based on 
combined therapy with adjuvant chemotherapy, 
surgical resection and radiotherapy. 
Prognosis 
Combined therapies have largely improved the 
prognosis of Ewing's tumours in the recent years; the 
prognosis is mainly determined by the presence of 
metastases at the time of diagnosis (15 to 35% of the 
cases); the 5-year survival rate is 10-35% in patients 
with mestastases, and 54-74% for patients with a 
localised disease at presentation. 
Cytogenetics 
Cytogenetics, morphological 
About 90% of Ewing's tumours, whatever their type,  
show a t(11;22)(q24;q12); the translocation results in 
the fusion of the EWS gene with the transcription  
factor gene FLI1, leading to a hybrid transcript and an 
oncogenic chimeric protein; in about 5% of the cases,  
the EWS gene is involved in variant translocations: 
t(21;22)(q12;q12) and t(7;22)(p22;q12), leading to 
fusions EWS-ERG and EWS-ETV1, respectively. 
Additional anomalies 
Additional anomalies in Ewing's tumours mainly 
consist in chromosome gains: +8 (45% of the cases) 
and, with a much lower frequency, trisomies 2, 5, 7, 9, 
12 (between 10 and 15% of the cases); trisomy 1q, 
through unbalanced t(1q;16q), is observed in about 
25% of the cases. 













t(11;22)(q24;q12) in Ewing sarcoma, G- banding - top: courtesy Jean Luc Lai (with trisomy 8 on the right); - bottom: courtesy G. Reza 
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N terminal domain of EWS protein with DNA binding 
domain of FLI1, ERG (ETS family genes). 
Oncogenesis 
Through transcription dysregulation. 
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